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Paternal Uniparental Isodisomy of Chromosome 20q—and the Resulting
Changes in GNAS1 Methylation—as a Plausible Cause of
Pseudohypoparathyroidism
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1Endocrine Unit, Department of Medicine, and 2MassGeneral Hospital for Children, Massachusetts General Hospital, and Harvard Medical
School, Boston; and 3Division of Pediatric Endocrinology, Department of Pediatrics, Stony Brook School of Medicine, State University of New
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Heterozygous inactivating mutations in the GNAS1 exons (20q13.3) that encode the a-subunit of the stimulatory
G protein (Gsa) are found in patients with pseudohypoparathyroidism type Ia (PHP-Ia) and in patients with pseudo-
pseudohypoparathyroidism (pPHP). However, because of paternal imprinting, resistance to parathyroid hormone
(PTH)—and, sometimes, to other hormones that require Gsa signaling—develops only if the defect is inherited
from a female carrier of the disease gene. An identical mode of inheritance is observed in kindreds with pseudo-
hypoparathyroidism type Ib (PHP-Ib), which is most likely caused by mutations in regulatory regions of the maternal
GNAS1 gene that are predicted to interfere with the parent-specific methylation of this gene. We report a patient
with PTH-resistant hypocalcemia and hyperphosphatemia but without evidence for Albright hereditary osteodys-
trophy who has paternal uniparental isodisomy of chromosome 20q and lacks the maternal-specific methylation
pattern within GNAS1. Since studies in the patient’s fibroblasts did not reveal any evidence of impaired Gsa protein
or activity, it appears that the loss of the maternal GNAS1 gene and the resulting epigenetic changes alone can
lead to PTH resistance in the proximal renal tubules and thus lead to impaired regulation of mineral-ion homeostasis.
Pseudohypoparathyroidism type Ia (PHP-Ia [MIM
300800]) is characterized by end-organ resistance to
parathyroid hormone (PTH) and several other hor-
mones—such as thyroid-stimulating hormone (TSH)—
that mediate their effects through the stimulatory G
protein (Gs) (for review, see Levine 1996; Weinstein
1998; Bastepe and Ju¨ppner 2000). Patients affected by
PHP-Ia show, in addition to hormone resistance, various
developmental defects referred to as “Albright heredi-
tary osteodystrophy” (AHO [MIM 300800]), including
a characteristically round face, short stature, obesity,
brachydactyly, heterotopic ossifications, and various de-
grees of mental retardation. PHP-Ia is caused by molecu-
lar defects in GNAS1 (MIM 139320), the gene encoding
the a-subunit of Gs (Gsa), as well as several splice variants
and antisense transcripts with yet-unknown biological
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roles (Hayward et al. 1998a, 1998b; Peters et al. 1999;
Hayward and Bonthron 2000; Wroe et al. 2000). Nu-
merous mutations throughout most Gsa-specific exons
lead to an ∼50% reduction in both Gsa activity and pro-
tein in circulating blood cells and fibroblasts. These mu-
tations can also cause AHO without hormonal resistance,
a condition termed “pseudo-pseudohypoparathyroidism”
(pPHP [MIM 300800]). PHP-Ia and pPHP are typically
present within the same kindreds but are never present
within the same sibships. Analysis of the parental origin
of Gsa mutations in these kindreds has indicated that,
although AHO is observed regardless of the parent trans-
mitting the defect, the expression of hormonal resistance
requires maternal transmission (i.e., pPHP—AHO
only—develops if the mutation is inherited from a male
carrier, whereas PHP-Ia—AHO and hormonal resis-
tance—is the phenotype if inheritance is from a female
affected by either of these disorders) (Davies and Hughes
1993; Wilson et al. 1994; Nakamoto et al. 1998). Con-
sistent with this mode of inheritance, renal PTH resistance
in mice with an ablation of the maternal exon 2 of Gnas,
genotype /m, but not in mice with ablation of this
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Table 1
Laboratory Findings for K-1, on Diagnosis and 2 mo after Initiation
of Therapy with Calcium and 1,25(OH)2D3
TREATMENT
SERUM AND URINE LEVELSa
On
Admission
After
2 Mo Reference Range
Calcium (mmol/liter) 1.80 2.28 2.10–2.65
Phosphorus (mmol/liter) 2.62 2.07 .8–1.45
PTH (pg/ml) 113 243 11–54
TSH (mIU/ml) ND 6.4 .4–5.0
Thyroxine (mg/dl) ND 4.9 4.5–12.5
25-OHD3 (ng/ml) 41 ND 10–60
1,25(OH)2D3 (pg/ml) 50 ND 16–46
Urinary calcium/creatinineb ND !.001 !.2
a ND p not determined.
b Measured in spot urine.
exon from the paternal allele, genotype /p, shows re-
nal PTH resistance (Yu et al. 1998).
As do individuals affected by PHP-Ia, patients affected
by pseudohypoparathyroidism type Ib (PHP-Ib [MIM
300800]) show PTH-resistant hypocalcemia and hyper-
phosphatemia but typically have no additional endo-
crine abnormalities. Furthermore, unlike PHP-Ia/pPHP,
PHP-Ib is not associated with AHO, and the PTH re-
sistance in PHP-Ib appears to be limited to the proximal
tubular cells of the renal cortex (Yamamoto et al. 1988;
Farfel 1999). An autosomal dominant form of PHP-Ib
has been linked to a chromosome 20q13.3 region that
comprises GNAS1, and the phenotypic expression of
PTH resistance has been shown to be dependent on ma-
ternal transmission of the genetic defect (Ju¨ppner et al.
1998) (i.e., the mode of inheritance for hormonal resis-
tance is identical to that observed in kindreds with PHP-
Ia/pPHP). Furthermore, several sporadic and familial
cases of PHP-Ib have been demonstrated to carry
GNAS1 methylation defects (Liu et al. 2000), making
it likely that mutations in a cell- or tissue-specific regu-
latory element of GNAS1 are responsible for PHP-Ib.
We now report a patient, K-1, who presented with
renal resistance to PTH but showed no evidence of
AHO. Analysis of K-1’s genomic DNA revealed a du-
plication of the paternal copy of chromosome 20q, with
loss of the maternal homolog (patUPD20q). Informed,
written consent was obtained (Massachusetts General
Hospital Institutional Review Board form 92-7338).
K-1 was born after 41 wk of an uneventful gestation;
maternal age at delivery was 39 years. Besides transient
hypoglycemia and neonatal hyperbilirubinemia requir-
ing 60 h of phototherapy, K-1 had right-lambdoid syn-
ostosis, which required surgical correction at age 13 mo.
K-1 was furthermore noted to have developmental de-
lay during infancy—he sat at age 16 mo, walked at age
19 mo, and said “mama” at age 24 mo—and therefore
received speech, occupational, and physical therapy
starting at age 2 years. The karyotype was normal
46,XY. K-1’s mother’s height is 185.4 cm (3.65 SD),
and his father’s height is 188.0 cm (1.7 SD). He has
a sister 3 years older, of normal stature, and in good
health; her calcium, phosphorus, and PTH have been
normal. There is no family history of any calcium dis-
orders or of hypothyroidism.
At the age of 5 years 3 mo, K-1 presented to another
hospital, with a tonic-clonic seizure, and was found to
be hypocalcemic and hyperphosphatemic, with an ele-
vated level of serum PTH (table 1). PHP was diagnosed,
and treatment with calcium carbonate (initially 164 mg/
kg/d) and 1,25 dihydroxy vitamin D (initially 17 ng/kg/
d) was initiated. After 2 mo of therapy, total serum cal-
cium was normal, but PTH remained elevated, which
prompted adjustments in medication. At that time, TSH
was also found to be slightly increased, with a low-
normal T4 (neonatal T4 was 12.7 mg/dl [normal range
10–28 mg/dl]); therefore, treatment with thyroxine (1.7
mg/kg/d) was initiated. Calcitonin was measured on two
occasions and was found to be 22 pg/ml and 31 pg/ml
(normal range !8.0 pg/ml).
At age 5 years 11 mo, when K-1 presented to one of
our institutions (i.e., A.H.L.’s), his height was 133.0 cm
(3.6 SD), his weight was 30.4 kg (3.4 SD) and his
head circumference was 54.7 cm (2.0 SD). Apart from
irregularly and widely spaced teeth and upturned,
cracked fingernails, no obvious abnormalities were re-
vealed by the physical exam. He did not have thyro-
megaly. Deep tendon reflexes were slightly hyperactive.
His coordination and balance, as well as his range of
motion, particularly in the trunk, were moderately lim-
ited, but his neurological examination was otherwise
normal. At age 6 years, K-1 did not have any features
of AHO; his height and weight were above the normal
range, and x-rays of both hands showed normal bone
age (on the basis of the standard of Greulich and Pyle),
without evidence for short metacarpals. According to
his parents, K-1’s language and reading comprehension
improved significantly during the year following initia-
tion of treatment with calcium, calcitriol, and thyroxine;
in contrast, his remaining neurological and physical
signs did not improve. Currently, he is in first grade and
is reported, by his teachers, to be reading at a third-
grade level.
To obtain insight into the molecular defect responsible
for the form of PHP evidenced by K-1, we searched in
genomic DNA, both from K-1 and from his immediate
family, for possible deletions/rearrangements in the chro-
mosome 20q region that encompasses GNAS1. Muta-
tions in this gene have been implicated in different forms
of PHP. The analysis of microsatellite markers (Ju¨ppner
et al. 1998; Bastepe et al. 1999) amplified from leukocyte
and fibroblast DNA indicated loss of heterozygosity
(LOH) for K-1, with a lack of maternal contribution at
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Figure 1 A, Haplotype analysis of genomic DNA from K-1 and his immediate family (K-2p sister; K-3p mother; K-4p father), across
chromosome 20. The fully informative markers on 20q reveal LOH for K-1, with a lack of maternal contribution. B, Schematic presentation
of GNAS1 gene (top) and allele-specific methylation of GNAS1, in K-1 and his relatives (bottom). Exons encoding sense transcripts are depicted
by white boxes; those encoding antisense transcripts are depicted by gray boxes. Thicker lines indicate probes used in Southern analysis: NESP55
(nucleotides 317–1705; GenBank accession number AJ009849), XLas (nucleotides 80–1693; GenBank accession number AJ224868), AS (nu-
cleotides 11646–13156; GenBank accession number AJ251760), and A/B (nucleotides 28580–31035; GenBank accession number AL121917).
Normal methylation status of the parental alleles is marked by a plus sign () or a minus sign (). Exons 1–3, encoding portions of Gsa, are
depicted by black boxes; exons 4–13 are not included. Combinations of restriction enzymes—Bg p BglII; P p PvuI; E p EcoRV; F p FspI;
S p SacI; N p NotI; B p BamHI; Nr p NruI (note that the small internal fragments of the EcoRV/FspI digest were not transferred)—are
indicated below autoradiographies, and the sizes (in kb) of the expected DNA fragments are indicated.
eight fully informative markers that are distributed
throughout chromosome 20q (fig. 1A). Informative mark-
ers located in 20p showed normal Mendelian inheritance,
and the analysis of at least one fully informative marker
for each of the other chromosomal arms revealed no ad-
ditional abnormalities (data not shown). Together with
the karyotype analysis, which did not indicate a large 20q
deletion (data not shown), these findings led to the con-
clusion that K-1 has patUPD20q.
GNAS1 has been previously demonstrated to exhibit
parent-specific methylation and expression (Hayward et
al. 1998a, 1998b; Hayward and Bonthron 2000; Liu et
al. 2000). To assess the pattern of methylation in this
gene, blood-leukocyte genomic DNA from K-1 and from
his healthy sister and parents was incubated with a com-
bination of methylation-sensitive and methylation-in-
sensitive restriction enzymes. Southern blot analyses us-
ing probes specific for four differentially methylated
GNAS1 regions revealed abnormalities in the patient’s
genomic DNA, at all four loci (fig. 1B), whereas the
healthy family members showed a methylation pattern
identical to that previously described for healthy indi-
viduals (Hayward et al. 1998a, 1998b; Hayward and
Bonthron 2000). The methylation abnormalities in K-1
were documented for at least one other site in each dif-
ferentially methylated region, by a different methylation-
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Figure 2 A, Basal cAMP accumulation (white bars), and accu-
mulation of this second messenger after challenge with 1 mM of either
PTH(1-34) (gray bars) or isoproterenol (black bars), in fibroblasts
derived from K-1 and his parents, K-3 and K-4. The data represent
the mean SEM of three independent experiments. B, Assessment of
Gsa-protein levels by western blot analysis. Equal amounts of protein
were loaded in each lane and were separated by 9% SDS-PAGE. After
transfer to nitrocellulose, detection of Gsa protein was achieved with
an anti-Gsa antibody and a horseradish peroxidase–labeled second
antibody. The positions of protein size markers (in kD) are indicated.
The findings are representative of four independent experiments with
similar results.
sensitive restriction enzyme (data not shown). Further-
more, results indistinguishable from those obtained with
blood-leukocyte DNA were obtained with fibroblast
DNA from K-1 and his parents (data not shown). Thus,
consistent with the haplotype analysis, which provided
evidence for paternally inherited DNA only, K-1 shows
a lack of a maternal methylation pattern within GNAS1
(i.e., the regions around exons AS, XL, and A/B are not
methylated at all, whereas the region around exon
NESP55 is methylated on both alleles).
To rule out the possibility that a Gsa-protein defect/
deficiency is responsible for the observed PTH resistance,
we investigated fibroblasts derived from K-1 and from
his healthy parents. Fibroblast cultures from K-1, his
mother, and his father showed similar basal cAMP
accumulation— , , and1.21 0.23 0.92 0.05 1.08
pmol/well, respectively. On challenge with either0.29
PTH(1-34) or isoproterenol (both 1 mM), the cAMP level
in K-1’s fibroblast cultures increased 5.7- and 48-fold,
respectively, and these increases were almost identical to
the findings for the parents’ cells (5.0- and 46-fold, re-
spectively, for the mother, and 5.0- and 34-fold, respec-
tively, for the father; fig. 2A). In addition, western blot
analysis of cell lysates, performed with a Gsa-specific
antibody (Yu et al. 1998), revealed no evidence for re-
duced Gsa-protein level in K-1’s fibroblasts (fig. 2B).
Uniparental disomies (UPDs) can lead to disease either
through the unmasking of recessive traits or, as observed
in some human disorders, through disrupted expression
of imprinted genes that is due to unbalanced parental
contribution (Kotzot 1999; Tilghman 1999; Nicholls
2000; Robinson 2000). GNAS1 and its murine homolog
give rise to several alternatively spliced transcripts that
are derived from either the paternal or the maternal allele
(Hayward et al. 1998a, 1998b; Hayward and Bonthron
2000; Liu et al. 2000; Wroe et al. 2000). Furthermore,
data from mice with either /p or /m ablation of
Gnas exon 2 indicate that Gsa transcripts, which show
broad biallelic expression, are derived, in some tissues
(such as the renal cortex), from the maternal allele alone
(Yu et al. 1998). We thus propose that the mechanism
underlying hormonal resistance in K-1 involves silencing
of Gsa transcription from the two normal paternal al-
leles in proximal renal tubules and that the resulting lack
of Gsa protein leads to PTH resistance in that tissue.
A GNAS1 methylation pattern similar to that observed
in K-1 was recently reported elsewhere for some PHP-Ib
cases (Liu et al. 2000). In that study, all investigated pa-
tients (11 sporadic cases and 2 familial cases) showed a
complete loss of methylation at exon A/B, which sug-
gested that a loss of methylation at the A/B locus and the
consequent active transcription from this promoter could
be involved, directly or indirectly, in the tissue-specific
silencing of Gsa transcription. The loss of exon A/B
methylation in patient K-1, albeit due to the lack of the
maternal GNAS1 gene rather than to a mutation, could
thus explain the kidney-specific PTH resistance. Notably,
two of the patients with PHP-Ib who have been reported
by Liu et al. revealed a more generalized methylation de-
fect, which involved, besides exon A/B, the other differ-
entially methylated GNAS1 regions—namely, NESP55,
XL, and the promoter of AS (Liu et al. 2000). It thus
appears likely that a complete lack of maternal-specific
methylation, which is indistinguishable from the epige-
netic changes observed in the patUPD20q described here,
can also be caused by mutations in regulatory regions of
the maternal GNAS1 allele.
The elevation of TSH with a low-to-normal T4 level,
which is comparable to that typically observed in patients
with PHP-Ia (Levine 1996; Weinstein 1998), suggests that
K-1 also had mild resistance to TSH. Thus, paternal si-
lencing of Gsa transcription may also take place, at least
partially, in the thyroid gland, which correlates with the
observation in kindreds with PHP-Ia/pPHP in which TSH
resistance is subject to paternal imprinting (Levine 1996;
Weinstein 1998). It is furthermore plausible that the ob-
served elevation of calcitonin reflects resistance in calci-
tonin-responsive tissues. On the other hand, the absence
of AHO in K-1 probably indicates that expression of the
intact Gsa protein is not impaired in the growth plates;
this finding contrasts with the findings in patients with
PHP-Ia or pPHP, who express a mutant Gsa transcript
from the maternal or paternal GNAS1 allele, respectively
(Levine 1996; Bastepe and Ju¨ppner 2000).
It is uncertain whether the craniosynostosis observed
in K-1 is related to the documented patUPD20q and to
an associated functional impairment of yet another im-
printed gene in this chromosomal region. The neuronatin-
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Figure 3 Genetic mechanisms that are predicted to underlie the
different forms of PHP. In healthy individuals (normal), the paternal
allele (P) gives rise to sense and antisense transcripts (solid-shaft ar-
rows) that are derived from the nonmethylated promoter regions up-
stream of exons XL, AS, and A/B, whereas the transcript that encodes
NESP55 is derived from the maternal allele (M). Note that Gsa tran-
scripts are derived in proximal renal tubules and possibly in other
tissues from the maternal allele and not from the paternal allele (dot-
ted-shaft arrows). In patients with PHP-Ia, mutations within 1 of the
13 Gsa-specific exons on the maternal allele (thick X) lead to either
a complete lack of Gsa protein or a functionally impaired protein. In
contrast, patients with PHP-Ib are presumed to carry a mutation in
regulatory regions of the maternal GNAS1 allele (light X, over “Gas”)
that causes loss of imprinting at exon A/B and that leads to impaired
Gsa expression in some tissues (tripled X). Lack of a maternal GNAS1
allele—as in K-1, who has patUPD20q—is predicted to result in a lack
of Gsa transcripts in the renal cortex that leads to PTH-resistant hy-
pocalcemia and hyperphosphatemia.
encoding gene, NNAT, which maps to the chromosomal
region 20q11.2-q12 (Dou and Joseph 1996), has been
shown, in the mouse, to be methylated on only the ma-
ternal allele and to exhibit exclusive paternal expression
(Kikyo et al. 1997). Similar findings (i.e., lack of NNAT
methylation on both paternally derived copies of chro-
mosome 20q) were observed in K-1 (data not shown).
Nonetheless, the duplication of the paternal NNAT is
unlikely to provide an explanation, since the equivalent
genetic modification in the mouse was not found to be
associated with significant abnormalities (Kikyo et al.
1997). Alternatively, K-1’s craniosynostosis may be the
result of an inherited recessive mutation unmasked be-
cause of isodisomy. Identification and clinical character-
ization of patients with a genetic abnormality either the
same as or similar to that in K-1 will help address these
questions.
Several different scenarios have been proposed to ex-
plain UPD formation (Kotzot 1999; Robinson 2000),
including gametic complementation, “trisomy rescue,”
and compensatory, mitotic duplication in monosomic
gametes. In addition to these mechanisms that function
to correct aneuploidy, postfertilization early-mitotic er-
rors that occur in initially normal gametes also can give
rise to UPD (Kotzot 1999; Robinson 2000). The ad-
vanced maternal age (39 years) in the case described in
the present study suggests that possible meiotic nondis-
junction resulted in an aneuploid female gamete. How-
ever, the findings with several different markers revealed
a partial UPD involving only the long arm of chromo-
some 20, thus strongly suggesting a postzygotic somatic
recombination event as the cause of patUPD20q in K-1.
UPD has been reported for most other chromosomes,
but only few previously reported patients have shown
duplications involving chromosome 20. For example,
one of these cases, a child with severe pre- and postnatal
growth retardation and hyperactivity, was shown to
have a complete maternal UPD of chromosome 20
(matUPD20; combined hetero- and isodisomy) and a
small marker chromosome (Chudoba et al. 1999). No
abnormalities of mineral-ion homeostasis were noted in
either this patient with matUPD20 or a parthenogenetic
chimera reported elsewhere (Strain et al. 1995). In ac-
cordance with current evidence indicating that Gsa tran-
scripts are derived in the renal cortex predominantly
from the maternal GNAS1 allele, these data suggest that
a complete lack of the paternal chromosome 20 is not
associated with PTH resistance. However, because the
AS transcript (as well as the XLas and A/B splice var-
iants) is derived from the paternal GNAS1 allele only,
some of the abnormalities in cases of matUPD20 may
be attributable to the complete silencing of these gene
products. Only a single preliminary report has described
a patient with paternal UPD involving the entirety of
chromosome 20 (Spinner et al. 1994). Karyotype analy-
sis in the latter case revealed mosaicism for trisomy 20
in several tissues, in addition to a terminal rearrange-
ment at the distal short arms of the two paternal chro-
mosome 20 homologs. On the basis of the reported
cytogenetic and microsatellite data, this patient would
be predicted to show laboratory abnormalities similar
to those which we have observed in K-1, but no details
were provided (Spinner et al. 1994). The scarcity of
reports suggests a severe, possibly lethal, nature for
complete paternal UPD20.
In conclusion, it appears that at least three different
GNAS1-related genetic mechanisms can lead to renal
PTH resistance (fig. 3): (i) heterozygous—maternal mu-
tations in exons encoding the Gsa transcript (as observed
in PHP-Ia); (ii) heterozygous—maternally derived mu-
tations in regulatory elements, which are associated with
loss of methylation at one or more exons (as observed
in PHP-Ib); and (iii) paternal UPD of the chromosomal
region comprising GNAS1, with the resulting loss of the
maternal-specific methylation pattern (as observed in
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K-1). The presence of AHO provides an important cri-
terion for establishing the diagnosis of PHP-Ia. However,
clinical findings cannot be used to distinguish between
PHP-Ib and patUPD20q. For genetic-counseling pur-
poses and to potentially gain additional insights into the
role of distinct GNAS1 regions in hormonal resistance,
it will therefore be important both to assess the methy-
lation status of different GNAS1 exons in patients with
PHP and to search in these individuals for the presence
of UPD in the telomeric end of chromosome 20q.
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